IL1B and neoplasm: The presence of bacteria in the pancreas can stimulate resident leukocytes to produce Interleukin-1β (IL-1β), which produces proangiogenic factors in the tumour microenvironment (TME) (e.g., Vascular Endothelial Growth Factor (VEGF), Tissue Necrosis Factor (TNF)) [14].